These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 19237096)

  • 1. Intravenous immunoglobulins-induced eczematous eruption: a long-term follow-up study.
    Cohen Aubart F; Barete S; Amoura Z; Francès C; Lyon-Caen O; Lebrun-Vignes B
    Eur J Intern Med; 2009 Jan; 20(1):70-3. PubMed ID: 19237096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severe eczematous skin reaction after high-dose intravenous immunoglobulin infusion: report of 4 cases and review of the literature.
    Vecchietti G; Kerl K; Prins C; Kaya G; Saurat JH; French LE
    Arch Dermatol; 2006 Feb; 142(2):213-7. PubMed ID: 16490849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pompholyx and eczematous reactions associated with intravenous immunoglobulin therapy.
    Gerstenblith MR; Antony AK; Junkins-Hopkins JM; Abuav R
    J Am Acad Dermatol; 2012 Feb; 66(2):312-6. PubMed ID: 21601310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Eczematous reactions after intravenous immunoglobulin therapy in two patients with Guillain-Barré syndrome and a patient with Miller Fisher syndrome].
    Tada M; Tada M; Ishiguro H; Yagi E; Hirota K
    No To Shinkei; 2003 May; 55(5):401-5. PubMed ID: 12833881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous immunoglobulin-induced severe vesicular eczematous eruption successfully treated with narrow band-ultraviolet B therapy.
    Koizumi R; Fukumoto T; Jimbo H; Nishigori C
    Photodermatol Photoimmunol Photomed; 2021 Sep; 37(5):371-373. PubMed ID: 33559335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequency of adverse events associated with intravenous immunoglobulin therapy in patients with pemphigus or pemphigoid.
    Gürcan HM; Ahmed AR
    Ann Pharmacother; 2007 Oct; 41(10):1604-10. PubMed ID: 17785614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dyshidrotic-like spongiotic dermatitis after intravenous immunoglobulin therapy.
    Uyttendaele H; Obadiah J; Grossman M
    J Drugs Dermatol; 2003 Jun; 2(3):337-41. PubMed ID: 12848120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short and long-term effect of IVIg in demyelinating neuropathy associated with MGUS, experience of a monocentric study.
    Théaudin M; Lozeron P; Lacroix C; Chrétien P; Ducot B; Denier C; Adams D
    Rev Neurol (Paris); 2011 Dec; 167(12):897-904. PubMed ID: 22023823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delayed eczematous skin reaction as an adverse drug reaction to immunoglobulin infusions: A case series.
    Barthel C; Musquer M; Veyrac G; Bernier C
    Ann Dermatol Venereol; 2022 Dec; 149(4):264-270. PubMed ID: 35753818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous immunoglobulin-induced, non-eczematous, vesiculobullous eruptions in Stevens-Johnson syndrome.
    Lin WL; Lin WC; Chang YC; Yang LC; Hung SI; Hong HS; Chung WH
    Am J Clin Dermatol; 2009; 10(5):339-42. PubMed ID: 19658448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dyshidrotic eczema and seborrheic dermatitis-like eczematous eruption following intravenous immunoglobulin therapy.
    Takci Z; Guler Simsek G; Uzuner H; Akbayrak A; Yıldız Seckin H; Karadag AS
    Dermatol Ther; 2020 Nov; 33(6):e14147. PubMed ID: 32767429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pompholyx of the hands after intravenous immunoglobulin therapy for clinically isolated syndrome: a paediatric case.
    Brazzelli V; Grassi S; Savasta S; Ruffinazzi G; Carugno A; Barbaccia V; Marseglia GL; Borroni G
    Int J Immunopathol Pharmacol; 2014; 27(1):127-30. PubMed ID: 24674688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usefulness of high-dose intravenous human immunoglobulins treatment for refractory recurrent pericarditis.
    Moretti M; Buiatti A; Merlo M; Massa L; Fabris E; Pinamonti B; Sinagra G
    Am J Cardiol; 2013 Nov; 112(9):1493-8. PubMed ID: 23972350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Multifocal motor neuropathy: a retrospective study of the response to high-dose intravenous immunoglobulin (IVIg) and current perspectives for diagnosis and treatment].
    Léger JM; Viala K; Maisonobe T; Bouche P
    Bull Acad Natl Med; 2007 Oct; 191(7):1395-407; discussion 1407-9. PubMed ID: 18447061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous and subcutaneous immunoglobulins-associated eczematous reactions occur with a broad range of immunoglobulin types: A French national multicenter study.
    Voland P; Barthel C; Azzouz B; Raison-Peyron N; Du-Thanh A; Staumont-Sallé D; Jachiet M; Soria A; Nosbaum A; Valois A; Leleu C; Lebrun-Vignes B; Trenque T; Hettler D; Bernier C; Viguier M;
    J Am Acad Dermatol; 2023 Feb; 88(2):380-387. PubMed ID: 36252685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of thromboembolic risk related to high-dose intravenous immunoglobulin treatment: a preliminary clinical study of 10 patients with autoimmune mucocutaneous blistering diseases.
    Mignogna MD; Fortuna G; Leuci S; Ruoppo E; Adamo D; Fedele S
    Clin Exp Dermatol; 2009 Mar; 34(2):145-50. PubMed ID: 19187294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term evolution of anti-ganglioside antibody levels in patient with chronic dysimmune neuropathy under IVIg therapy.
    Matà S; Borsini W; Caldini A; De Scisciolo G; Piacentini S; Taiuti R
    J Neuroimmunol; 2006 Dec; 181(1-2):141-4. PubMed ID: 17023053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eczema and X-linked agammaglobulinaemia.
    Hunter HL; McKenna KE; Edgar JD
    Clin Exp Dermatol; 2008 Mar; 33(2):148-50. PubMed ID: 18076688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Exfoliative dermatitis as a side effect of intravenous immunoglobulin treatment].
    Markvardsen LH; Jakobsen J
    Ugeskr Laeger; 2011 Oct; 173(43):2725-6. PubMed ID: 22027232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vesicular and bullous eczema in response to intravenous immunoglobulins (IVIG).
    Maetzke J; Sperfeld AD; Scharffetter-Kochanek K; Sunderkötter C
    Allergy; 2006 Jan; 61(1):145-6. PubMed ID: 16364173
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.